|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||10.35 / 38.50|
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
Which stocks have been the biggest dogs on Wall Street since the start of the calendar 2017 year?
Ackman, who skipped last year's conference, will take the stage on May 8.
The Street took a look at the top 15 activist hedge funds and their director-election records over the past six years
The Wall Street lawyer told lawmakers on Capitol Hill that he sees "meaningful" room to bolster the current lackluster IPO markets.
CEO Joseph Papa takes home approximately $62.7 million yearly.
The Street took a look at the top activist hedge funds and their director-election records over the past six years.
Valeant shares were down nearly 2% at one point on news that it has completed several refinancing transactions.
Also on the move were Global Blood Therapeutics, Valeant and Kite Pharma, among others.
Doug Kass shares his thoughts on Pershing Square, and talks about Sears.
TheStreet's Jim Cramer discusses the hottest stocks of the day on our daily Facebook Live show, airing weekdays at 10 a.m. EST.
A new study shows U.S. employees love their employee stocks and stock options, and like to exercise them early and often.
Managing risk requires accepting that you'll be wrong sometimes and planning accordingly; just ask Bill Ackman.
Stocks churn around the flatline to end the week as a selloff in health care counters gains seen elsewhere.
Stocks rise on Friday even as a selloff in health care extends into its second day.
Stocks creep lower on Friday as a selloff in health care extends into its second day.
Oil and natural gas prices are on the downswing and one key measure seems to pointing that we could be nearing a pullback in the S&P.
Stock futures move mostly higher on Friday as crude oil attempts another rebound to close out the week.
The move comes just days after Bill Ackman's Pershing Square exited the stock.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is confident hedge fund manager Bill Ackman will rebound from his multi-billion dollar loss in Valeant Pharmaceuticals.
We have repurchased the short March 17 puts this morning, while selling a March 17 $12 call, to ensure it will be in the black and keep more upside on the table.
Most traders will probably wait for the Fed-related dust to settle.
Carolyn Boroden charts Facebook, Apple and Tesla: Here's how tracking 5- and 13-day exponential moving averages can keep you out of the red.
John Ferriola, CEO of Nucor, tells Jim Cramer that 2017 is shaping up to be better than 2016.
Hamid Moghadam, CEO of Prologis, tells Jim Cramer that if you believe ecommerce will continue to grow, so will his company.
Jim Cramer says it's his job to educate and entertain you, as well as help you make and save money.
Jim Cramer is bullish on Cisco Systems, Check Point Software and CyberArk Software.